Skip to content
OpenCapital
Get started

Collegium Pharmaceutical, Inc. COLL Shares (Diluted)

Shares (Diluted) at other companies

Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc. INDV
129M+3.2%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
126.9M0.0%
Avanos Medical logo
Avanos MedicalAVNS
47.5M+1.5%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
40.9M-12.1%
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
57.6M+3.2%
Theravance Biopharma logo
Theravance BiopharmaTBPH
51.3M+3.2%

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+20.4%
Enterprise value$869.67M+2.5%
P/E15.4×-6.4×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0×0.0×
Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s shares (diluted)?
Collegium Pharmaceutical, Inc. (COLL) reported shares (diluted) of 40.1M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s shares (diluted) changed year-over-year?
Collegium Pharmaceutical, Inc.'s shares (diluted) increased by 22.0% year-over-year, from 32.8M to 40.1M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s shares (diluted)?
Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s shares (diluted) has grown at a -0.2% compound annual growth rate (CAGR), from 152.8M to 151.4M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.